Showing results (381-390 of 3,564) with videos related to
Sort By:
Pageof 357
Journal of Thrombosis and Thrombolysis|April 15, 2000
Anticoagulation Management as a Risk Factor for Adverse Events: Grounds for ImprovementAnsellJournal of Thrombosis and Thrombolysis|April 15, 2000
Optimal Frequency of Patient Monitoring and Intensity of Oral Anticoagulation Therapy in Valvular Heart DiseaseHorstkotte, Piper, WiemerJournal of Thrombosis and Thrombolysis|April 15, 2000
Outpatient Therapy of Deep Vein ThrombosisPineo, HullJournal of Thrombosis and Thrombolysis|April 15, 2000
Platelet Inhibition in Cardiovascular Disease Management: Aspirin and BeyondHarringtonJournal of Thrombosis and Thrombolysis|January 24, 2021
Assessment of provider practices regarding venous thromboembolism management and prevention in pediatric acute leukemia patientsMelanie Degliuomini, Victoria Cooley, Elizabeth Mauer, et al.Journal of Thrombosis and Thrombolysis|January 30, 2021
Pulmonary venous thrombosis in a patient with COVID-19 infectionAhmed K Pasha, Alejandro Rabinstein, Robert D McBaneJournal of Thrombosis and Thrombolysis|September 14, 2019
A case report of severe bleeding due to lupus anticoagulant hypoprothrombinemia syndromeElsa Meireles, Filipe Machado, Luís Teles, et al.Journal of Thrombosis and Thrombolysis|September 30, 2019
Drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine careMarkus Gulilat, Denise Keller, Bradley Linton, et al.Journal of Thrombosis and Thrombolysis|October 2, 2019
D-dimer levels at diagnosis and long-term clinical outcomes in venous thromboembolism: from the COMMAND VTE RegistryMaki Oi, Yugo Yamashita, Mamoru Toyofuku, et al.Journal of Thrombosis and Thrombolysis|September 8, 2019
Incidence of residual perfusion defects by lung scintigraphy in patients treated with rivaroxaban compared with warfarin for acute pulmonary embolismMing Sheng Lim, Dee Nandurkar, Ian Jong, et al.Pageof 357